[Progress in pain therapy exemplified by migraine. What does withdrawal treatment produce? Possibilities of prevention].
Wörz
R
R
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000009:adverse effects*; D001463:Barbiturates / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000628:therapy*
D000319:Adrenergic beta-Antagonists; D000701:Analgesics, Opioid; D001463:Barbiturates; D002121:Calcium Channel Blockers; D004876:Ergot Alkaloids; D012702:Serotonin Antagonists
Fortschritte der Schmerztherapie am Beispiel der Migräne. Was bringt eine Entzugsbehandlung? Möglichkeiten der Prophylaxe.